MOTTA, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 20.443
AS - Asia 2.866
EU - Europa 2.426
Continente sconosciuto - Info sul continente non disponibili 400
SA - Sud America 353
AF - Africa 42
OC - Oceania 4
Totale 26.534
Nazione #
US - Stati Uniti d'America 20.351
SG - Singapore 1.382
IT - Italia 596
CN - Cina 503
BR - Brasile 298
DE - Germania 274
UA - Ucraina 263
RU - Federazione Russa 256
HK - Hong Kong 217
KR - Corea 217
VN - Vietnam 203
IE - Irlanda 186
GB - Regno Unito 159
FR - Francia 158
SE - Svezia 153
BD - Bangladesh 117
PL - Polonia 104
FI - Finlandia 89
NL - Olanda 82
JP - Giappone 70
CA - Canada 65
IN - India 43
AR - Argentina 28
AT - Austria 23
ZA - Sudafrica 19
TR - Turchia 16
ES - Italia 15
CZ - Repubblica Ceca 14
UZ - Uzbekistan 14
BE - Belgio 13
EU - Europa 13
IQ - Iraq 13
ID - Indonesia 11
MX - Messico 10
EC - Ecuador 8
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
LT - Lituania 6
PK - Pakistan 6
CR - Costa Rica 5
DK - Danimarca 5
IL - Israele 5
RO - Romania 5
TN - Tunisia 5
AU - Australia 4
CO - Colombia 4
EG - Egitto 4
JM - Giamaica 4
PH - Filippine 4
PY - Paraguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CL - Cile 3
IR - Iran 3
KZ - Kazakistan 3
NO - Norvegia 3
NP - Nepal 3
RS - Serbia 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
DM - Dominica 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
OM - Oman 2
TH - Thailandia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 26.148
Città #
Woodbridge 5.497
Wilmington 5.199
Houston 4.501
Fairfield 628
Singapore 612
Ann Arbor 410
Ashburn 408
Chandler 348
San Jose 320
Seattle 237
Hong Kong 213
Beijing 208
Jacksonville 208
Council Bluffs 201
Rome 191
Cambridge 189
Dublin 177
Medford 137
New York 111
Santa Clara 106
Dearborn 104
Los Angeles 86
The Dalles 81
Kraków 78
Ho Chi Minh City 65
Lawrence 65
Tokyo 57
Hanoi 52
Buffalo 51
Lauterbourg 48
San Diego 47
Milan 44
Munich 44
Zhengzhou 44
Dallas 43
Moscow 41
Chicago 34
Manchester 32
Helsinki 31
Norwalk 29
São Paulo 26
London 24
Maastricht 23
Menlo Park 19
Palo Alto 19
Warsaw 19
Mülheim 17
Naples 17
Orem 17
Chennai 16
Düsseldorf 16
Johannesburg 16
Brooklyn 15
Hangzhou 15
Redondo Beach 15
Redwood City 15
Vienna 15
Atlanta 13
Brno 13
Brussels 13
Montreal 13
Amsterdam 12
Belo Horizonte 12
Boardman 12
Hefei 12
Mountain View 12
Salt Lake City 12
Seoul 12
Monte Vista 11
Nanjing 11
Phoenix 11
Tashkent 11
Toronto 11
University Park 11
Verona 11
Da Nang 10
Frankfurt am Main 10
Madrid 10
Nuremberg 10
Philadelphia 10
Rio de Janeiro 10
Denver 9
Pieve a Nievole 9
Poplar 9
San Francisco 9
Guangzhou 8
Kunming 8
Mumbai 8
North Bergen 8
Stockholm 8
Turku 8
Eijsden 7
Haiphong 7
Washington 7
Ankara 6
Bologna 6
Boston 6
Brescia 6
Columbus 6
Elk Grove Village 6
Totale 21.695
Nome #
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 610
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 585
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 526
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 520
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 503
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 499
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 485
Subclinical central inflammation is risk for RIS and CIS conversion to MS 481
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 476
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 471
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 470
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 468
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 468
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 468
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 464
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 464
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 452
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 451
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 450
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 445
Inflammation inhibits GABA transmission in multiple sclerosis 442
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 441
Disability and its progression can be objectively measured in multiple sclerosis 441
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 440
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation 439
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 434
Endovascular Stroke Treatment of Acute Tandem Occlusion: A Single-Center Experience 432
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 427
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis 425
Neural stem cell transplantation promotes post-ischemic neuronal plasticity by regulating the expression of glutamate transporters 425
The autonomic balance predicts cardiac responses after the first dose of fingolimod 423
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis 422
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 419
CT angiography-based collateral flow and time to reperfusion are strong predictors of outcome in endovascular treatment of patients with stroke 416
Plasmacytoid dendritic cells induce an immunoregulatory T helper 9 profile in multiple sclerosis 412
Efficacy and Safety of Mechanical Thrombectomy in Older Adults with Acute Ischemic Stoke 412
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis 409
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 406
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis 403
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 398
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 395
Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum 393
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis 393
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 387
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 386
CT angiography ASPECTS predicts outcome much better than noncontrast CT in patients with stroke treated endovascularly 382
Pretreatment predictors of malignant evolution in patients with ischemic stroke undergoing mechanical thrombectomy 382
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 377
Proposed chronic cerebrospinal venous insufficienty criteria do not predict multiple sclerosis risk or severity 372
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 371
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 354
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 318
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 273
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 268
Heparin during endovascular stroke treatment seems safe 212
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 202
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 194
Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study 188
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 181
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 175
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 159
Clinical and histological study of a xenogenic bone substitute used as a filler in postextractive alveolus 155
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 124
Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation 123
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 117
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 113
Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease 104
Effects of 52 weeks of precuneus rTMS in Alzheimer's disease patients: a randomized trial 102
Decreased Frontal Gamma Activity in Alzheimer Disease Patients 101
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients 95
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study 94
Functional correlates of microglial and astrocytic activity in symptomatic sporadic Alzheimer's disease: a CSF/18F-FDG-PET study 85
Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients 78
Improving visuo-motor learning with cerebellar theta burst stimulation: behavioral and neurophysiological evidence 65
Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer's Disease 63
Biobanking for Neurodegenerative Diseases: Challenge for Translational Research and Data Privacy 60
Intermittent cerebellar theta burst stimulation improves visuo-motor learning in stroke patients: a pilot study 56
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum 49
Rethinking dementia in the oldest old: Lessons to learn for the diagnosis and treatment of Alzheimer’s disease 42
Beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies 38
Opposing patterns of blood-brain barrier permeability and Alzheimer’s disease biomarkers across APOE genotype 37
Reframing TDP‐43 in Alzheimer's disease: From co‐pathology to neurovascular culprit 34
Reply to: letter to the editor regarding “beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies” 33
Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum. 32
Elevated plasma p-tau217 in newborns: developmental signal or synaptic stress marker? 28
Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial 26
Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection 22
Chronic fasudil treatment induces benzodiazepine-like tolerance via modulation of GABA-A receptor γ2 subunit expression and impairs contextual fear memory in mice 22
NOTCH3 variants of unknown significance underpin vascular dysfunction in neurodegenerative disease: a case series of three nfvPPA-FTD patients 19
An Out-of-Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic 18
Streamlining Alzheimer's disease diagnosis: real-world validation of two-cut-off diagnostic models based on plasma p-tau/Aβ42 ratios 15
Totale 26.534
Categoria #
all - tutte 62.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022732 0 98 75 37 26 84 36 28 54 55 50 189
2022/2023850 119 90 20 103 73 187 62 49 63 12 53 19
2023/2024254 37 7 22 12 22 70 12 4 3 5 8 52
2024/20252.154 66 374 179 113 74 256 112 89 149 176 321 245
2025/20263.514 249 161 373 262 312 124 460 357 457 281 275 203
2026/2027355 189 166 0 0 0 0 0 0 0 0 0 0
Totale 26.534